Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-08 Sale |
2020-12-10 5:04 pm |
Aerpio Pharmaceuticals Inc. | ARPO | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC 10% Owner |
21,400 | $1.96 | $41,944 | 5,193,946 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-01 Option Award |
2021-02-03 9:34 pm |
N/A 2031-02-01 |
Aerpio Pharmaceuticals Inc. | ARPO | Castelein Caley Director |
17,857 | $0 | 17,857 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 9:34 pm |
N/A 2031-02-01 |
Aerpio Pharmaceuticals Inc. | ARPO | Dalal Anupam Director |
17,857 | $0 | 17,857 (Direct) |
View |
| 2020-12-08 Exercise |
2020-12-10 5:04 pm |
N/A 2029-06-28 |
Aerpio Pharmaceuticals Inc. | ARPO | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC 10% Owner |
21,400 | $0 | 5,193,946 (Indirect) |
View |
| 2020-12-08 Exercise |
2020-12-10 5:04 pm |
N/A N/A |
Aerpio Pharmaceuticals Inc. | ARPO | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC 10% Owner |
21,400 | $0.96 | 5,193,946 (Indirect) |
View |